https://www.selleckchem.com/pr....oducts/compstatin.ht
Both 25G and 27G were safe and well tolerated MIVS platforms for the treatment of ERM and FTMH. Final visual outcomes improved for both 25G and 27G ERM groups and the 25G FTMH group. Both 25G and 27G were safe and well tolerated MIVS platforms for the treatment of ERM and FTMH. Pilot trials often use quantitative data such as recruitment rate and retention rate to inform the design and feasibility of a larger trial. However, qualitative data such as patient, healthcare provider, and research staff perceptions of an intervention may a
Мне нравится
Комментарий
Перепост
